2024
Ni L*, Fei C*, Fan Y*, Dang F*., et al. Mol. Cell. 84: 1-18 (2024).
Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry.
Ke S*, Dang F*, Wang L*, Chen JY*, et al. Nat. Commun. 15(1): 3220 (2024).
Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, Du G, Liu X, Dang F, et al. Sci. Immunol. 9(94): eadn1452. doi: 10.1126/sciimmunol.adn1452 (2024).
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.
Ma J, Li L, Ma B, Liu T, Wang Z, Ye Q, Peng Y, Wang B, Chen Y, Xu S, Wang K, Dang F, et al. Nat. Commun. 15(1): 1871 (2024).
2023
Dang F*, Bai L*, Dong J*, Hu X*, et al. Sci. Transl. Med. 15(725): eadh7668. doi: 10.1126/scitranslmed.adh7668 (2023).
Zhang T, Xu D, Trefts E, Lv M, Liu J, Liu M, Chu C, Wang M, Wang H, Meng H, Liu H, Zhuang Y, Xie X, Dang F, et al. Science, 380(6652): 1372-1380 (2023).
Oxygen-sensitive prolyl hydroxylation of RIPK1 suppresses its activation.
Zhang T, Xu D, Liu J, Wang M, Duan L, Lv M, Meng H, Liu M, Zhuang Y, Lee Y, Wang H, Shi L, Guo R, Liu H, Erickson E, Wang Y, Yu W, Dang F, et al. Nat. Cell Biol., 25(7): 950-962 (2023).
An intrinsic connection between COVID-19 and aging.
Wang J, Wei JCJ, Dang F, Inuzuka H. Acta Materia Medica 2 (3), 342-346
2022
Targeting the acetylation signaling pathway in cancer therapy.
Dang F, Wei W. Semin. Cancer Biol. 85: 209-218, doi: 10.1016/j.semcancer.2021.03.001 (2022).
2021
Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
Dang F*, Nie L*, Zhou J*, et al. Nat. Commun. 12(1): 5386 (2021).
Ubiquitin Signaling in Cell-cycle Control and Tumorigenesis.
Dang F, Nie L, Wei W. Cell Death & Differ. 28(2): 427-438 (2021).
PCAF and SIRT1 modulate βTrCP1 protein stability in an acetylation-dependent manner.
Dang F*, Jiang C*, Zhang T, Inuzuka H, Wei W. J Genet Genomics. 48(7): 652-655 (2021).
2019
PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage.
Zhang J*, Lee YR*, Dang F*, Gan W, Menon AV, Katon JM, Hsu CH, Asara JM, Tibarewal P, Leslie NR, Shi Y, Pandolfi PP, Wei W. Cancer Discov. 9(9): 1306-1323 (2019).
The Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex.
Wu R, Dang F, Li P, Wang P, Xu Q, Liu Z, Li Y, Wu Y, Chen Y, Liu Y. Cell Metab. 29(3): 653-667 (2019).
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.
Zhang J, Chen M, Zhu Y, Dai X, Dang F, et al. Dev. Cell, 48(3): 329-344 (2019).
2018
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.
Zhang J*, Dang F*, Ren J, Wei W. Trends Biochem. Sci. 43(12): 1014-1032 (2018).
2016
Insulin post-transcriptionall modulates Bmal1 protein to affect hepatic circadian clock.
Dang F*, Sun X*, Ma X, Wu R, Zhang D, Chen Y, Xu Q, Wu Y, Liu Y. Nat. Commun. 7: 12696 (2016).
Dang F, Wu R, Wang P, Wu Y, Azam MS, Xu Q, Chen Y, Liu Y. Sci. Rep. 6: 36926 (2016).
2015
Glucagon-CREB/CRTC2 signaling cascade regulates hepatic BMAL1 protein.
Sun X, Dang F, Zhang D, Yuan Y, Zhang C, Wu Y, Wang Y, Liu Y. J. Biol. Chem., 290(4): 2189-2197 (2015).
(* Equal contribution)
